Focused on Work, Needed at Home: A Federal Caregiving Policy Might Help
The Family and Medical Leave Act (FMLA) offers up to 12 weeks of job‑protected, unpaid leave for eligible employees caring for a seriously ill parent, spouse or child. Roughly 60% of U.S. workers meet the eligibility thresholds, but two‑thirds avoid taking leave because they cannot afford unpaid time off. Thirteen states and the District of Columbia now require paid family‑leave programs, and many employers allow concurrent use of accrued paid time off. Experts stress clear communication with managers to preserve job security and shift workplace culture toward supporting caregivers.
ASCO26: AZ Triplet Makes Waves in Frontline Liver Cancer
AstraZeneca’s three‑drug combo of Imfinzi, Imjudo and Lenvima, added to transarterial chemoembolisation (TACE), cut the risk of disease progression or death by 30 % in unresectable hepatocellular carcinoma. In the EMERALD‑3 trial the triplet extended median progression‑free survival (PFS) to 13 months...
La Cuna: Community-Led Spanish Perinatal Education and Social Needs Navigation for Hispanic Immigrant Families
La Cuna is a community‑led, Spanish‑language perinatal education and social needs navigation program launched in Arkansas for Hispanic immigrant families. From 2021‑2025 it served 498 participants, screening high rates of food insecurity (42‑45%), financial strain (43‑60%) and unemployment (38‑81%). The...
Updating California’s Adverse Childhood Experiences (ACEs) and Toxic Stress Risk Assessment and Response Algorithm
California’s ACEs Aware program, launched in 2020 to screen for adverse childhood experiences and toxic stress, has released an updated risk‑assessment and response algorithm. The revision was driven by a ten‑member national expert committee and validated through usability testing with...
Amgen Reports the EC Approval of Imdylltra to Treat ES-SCLC
Amgen’s bispecific antibody Imdylltra (tarlatamab) received European Commission approval for treating adults with extensive‑stage small cell lung cancer (ES‑SCLC) who have progressed after platinum‑based first‑line therapy. The decision follows the Phase III DELPHI‑304 trial, which enrolled 509 patients and compared Imdylltra...
Greywolf Reports Early Responses with Oral ERAP1 Inhibitor in Solid Tumours
Oxford‑based Greywolf Therapeutics presented Phase 1b data for its oral ERAP1 inhibitor GRWD5769 combined with the anti‑PD‑1 antibody cemiplimab across six solid‑tumour types at the 2026 ASCO meeting. The non‑randomised expansion cohorts, comprised of patients previously resistant to PD‑1 blockade, reported...
New Magnetic Particle Imaging Ensures Precision Cell Therapy Injection Tracking
Scientists at Johns Hopkins Medicine demonstrated that magnetic particle imaging (MPI) can track therapeutic cells in live mice, revealing real‑time distribution after injection. The NIH‑funded study, published May 6, 2026 in Science Advances, compared arterial and venous delivery of mesenchymal stem cells...
A ‘Credit-Score-Like’ Risk Assessment System for Investigative Drugs
VeriSIM Life has introduced a credit‑score‑like risk assessment tool within its BIOiSIM platform that predicts clinical trial success with roughly 90 % accuracy. The system blends mechanistic animal‑to‑human simulations with machine‑learning models, generating synthetic data to overcome limited experimental inputs. Around...
GLP-1 Drugs Like Ozempic Show Promise for More than Weight Loss. But What’s Science vs Hype?
GLP‑1 agonists such as Ozempic and Wegovy are moving beyond diabetes and obesity as researchers explore their potential in cardiovascular disease, liver disease, sleep apnea and other conditions. Large trials have shown semaglutide reduces heart attacks and strokes by 20%...
Nanofiber Bionic Skin Helps Infected Wounds Heal Faster in Preclinical Study
Researchers have engineered a Janus nanofiber dressing that mimics human skin, provides passive radiative cooling, and generates visible-light‑triggered reactive oxygen species for antibacterial action. The solvent‑welded PVDF nanofiber membrane achieves 21.6 MPa strength and 54% elongation, while iron‑doped ZIFs deliver a...
Five-mRNA Cocktail Shows Promise in Reducing Heart Failure Post-Myocardial Infarction
Researchers at Osaka University have developed a polyplex nanomicelle system that delivers a cocktail of five therapeutic mRNAs directly into infarcted heart tissue. In mouse models of post‑myocardial infarction heart failure, the treatment markedly improved left‑ventricular ejection fraction, reduced scar...
Researchers Develop Real Time Sensor System for Early Detection of ICU Brain Infections
A University of Waterloo team unveiled NeuroSense, a 3D‑printed, smartphone‑sized platform that continuously monitors cerebrospinal fluid for infection biomarkers and flow rate in ICU patients. The system tracks glucose, lactate, pH and fluid dynamics, delivering near‑real‑time alerts that could replace...
Targeting Hepcidin to Restore Oral Iron Efficacy After Vertical Sleeve Gastrectomy
Vertical sleeve gastrectomy (VSG) frequently triggers iron deficiency that oral iron supplements cannot correct. The study shows VSG elevates intestinal iron‑uptake proteins but provokes a disproportionate rise in hepatic hepcidin, which degrades ferroportin and traps iron in tissues. Curcumin, a...
Vitamin D Levels, General Health Status, and Work Productivity Among Healthcare Workers—A Scoping Review of Published Literature (2010–2025)
A systematic scoping review of 36 studies (2010‑2025) finds vitamin D deficiency highly prevalent among healthcare workers, with rates between 30% and over 90% depending on region, season, role and assay. The deficiency is most pronounced in nurses, shift workers and...
Brief Psychological Support for ‘Personality Disorders’: No Shortcut Found
A large UK randomised trial evaluated Structured Psychological Support (SPS), a brief, up‑to‑10‑session intervention for people with probable personality disorders. The study found SPS did not improve social functioning compared with enhanced treatment‑as‑usual and was not cost‑effective for the NHS....
Akeso’s Ivonescimab Meets Next Phase III Lung Cancer Goal, as Competitors Line Up
Akeso Therapeutics announced that its bispecific antibody ivonescimab met the primary overall‑survival endpoint in a Phase III trial for advanced non‑small cell lung cancer (NSCLC). The study showed a statistically significant survival benefit versus standard chemotherapy, with a manageable safety profile...
ATS 2026: Insmed Shines in Bronchiectasis with Spotlight on Brinsupri
Insmed used the 2026 American Thoracic Society meeting to showcase Brinsupri, its first‑to‑market DPP‑1 inhibitor for non‑cystic fibrosis bronchiectasis. The company presented post‑hoc Phase III ASPEN data indicating dose‑dependent improvements in patient‑reported respiratory symptoms and released a survey highlighting the disease’s...
Is an Emerging Pharmacotherapeutic Era for Rare Mitochondrial Diseases Here?
After decades of therapeutic void, mitochondrial disease care is entering a new pharmacologic era. In the past year the FDA approved elamipretide (Forzinity) for Barth syndrome and deoxynucleoside therapy (Kygevvi) for TK2 deficiency, marking the first disease‑specific drugs for these...
Nxera’s Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea
Nxera Pharma announced that South Korea’s Ministry of Food and Drug Safety granted Orphan Drug Designation (ODD) and Global Innovative Products on Fast Track (GIFT) status to its dissociative corticosteroid vamorolone for Duchenne muscular dystrophy (DMD). The ODD recognizes DMD...
Providence Study Finds Scale Unlocks the Value of Ambient AI-Assisted Clinician Documentation
A Providence‑wide study of 1,547 clinicians using ambient AI documentation showed immediate cuts in note‑writing time and a gradual decline in after‑hours charting, while productivity rose modestly via higher relative value units. The evaluation, covering 16,149 observation‑months between July 2023...
CMS Issues Interim Final Rule on Medicaid Community Engagement Requirements
On June 1, CMS issued an interim final rule that activates the statutory community‑engagement requirement for certain adult Medicaid beneficiaries. The rule mandates 80 hours per month of qualifying activities—such as employment, education, or community service—or the equivalent income threshold....
CMS Announces 80-Hour Medicaid Work Requirement Amid Home Care Concerns
The Centers for Medicare & Medicaid Services issued an interim final rule mandating an 80‑hour monthly work requirement for adult Medicaid beneficiaries aged 19 to 64, with several exemptions. CMS projects the rule could reduce Medicaid enrollment by 3.1‑3.3 million people...
EXECUTIVE FORUM ON DIGITAL PATHOLOGY MANAGEMENT 2
The Executive Forum on Digital Pathology Management 2 gathered top clinicians and technology leaders to examine current digital pathology workflows, artificial‑intelligence applications, and data‑integration challenges. Opening remarks were delivered by Christopher Garcia, Mayo Clinic’s Chief Digital Innovation Officer, followed by insights...
RNA 'Cut-and-Patch' Tool Repairs Faulty Messages without Altering DNA
University of Hong Kong researchers unveiled RNA Segment Editing (RSE), a "cut‑and‑patch" platform that precisely removes and replaces faulty RNA segments in living cells without altering DNA. The tool leverages an engineered Cas13 enzyme to achieve segment‑level editing, a capability...
Healthcare Affordability and Financial Sustainability Concerns Test CFO Strategy
Healthcare CFOs are grappling with the dual challenge of keeping care affordable while preserving financial sustainability. A recent HFMA‑hosted panel highlighted that only 17% of CFOs are fully committed to affordability, yet all surveyed leaders now feel compelled to act....
AHA Urges CMS Not to Finalize Provisions in FY 2027 Inpatient Psychiatric Facility Proposed Rule
The American Hospital Association (AHA) submitted comments to CMS on June 1 urging the agency not to finalize several provisions in the FY 2027 inpatient psychiatric facility (IPF) prospective payment system rule. The AHA argues that the proposed market‑basket update understates...
Policy Clarity Drives Hospitals’ M&A Surge
Hospital mergers and acquisitions surged to a six‑year high in 2026, with 22 deals announced in Q1, the strongest first‑quarter activity since 2020. The rise is driven by clearer policy guidance after the One Big Beautiful Bill Act and related...
How Bandera Works With Partners to Expand Nursing Home Service Lines
Bandera Healthcare, an Arizona operator of Ensign Group, is expanding its nursing‑home service lines through strategic partnerships with health plans, hospitals, and community agencies. The company now offers bariatric care, behavioral health, in‑house dialysis, substance‑abuse recovery and other specialized services...
President Signs EO on Childhood Immunization Schedule
The President signed an executive order that revises the U.S. childhood immunization schedule, aiming to tighten vaccine requirements amid rising infectious‑disease threats. The CDC released a series of alerts highlighting a 2025 measles outbreak in Utah that has surpassed 660...
Massachusetts Attorney General Sues UnitedHealthcare, Alleges $100M MassHealth Fraud
Massachusetts Attorney General Andrea Campbell sued UnitedHealthcare, accusing the insurer of manipulating health assessments to extract at least $100 million from the state Medicaid program, MassHealth. The allegations focus on the Senior Care Options plan, where United allegedly misclassified members into...
Clinical Workflow Automation: Where AI Is Making Real Inroads in Healthcare
Healthcare leaders are turning to AI‑driven clinical workflow automation to curb clinician burnout, fill staffing gaps, and speed up revenue‑cycle processes. Deloitte’s 2026 State of AI Report shows nearly 75% of health‑care organizations report efficiency gains from AI. Use cases...
Waypoint Bio Raises $20M Series A
Waypoint Bio, an AI‑native biotech based in New York, closed a $20 million Series A round led by Amplify Partners. The financing brings new board member Elliot Hershberg and adds General Catalyst, Time BioVentures, Mitsui Global Investments, and Lux Capital among others. The...
Intuitive Elevates Taylor Patton to Chief Commercial and Marketing Officer
Intuitive Surgical promoted veteran executive Taylor Patton to chief commercial and marketing officer effective July 1, succeeding Henry Charlton. Patton, who previously led the endoluminal business and launched the Ion lung‑biopsy robot, will oversee global commercial expansion as competition in robotic...
The Threat Landscape Is Evolving. How Can Healthcare Organizations Protect Themselves?
Cyber attackers targeting healthcare have accelerated, now moving from initial breach to lateral spread in under 30 seconds, according to CrowdStrike’s Global Threat Report. This speed compresses detection and response windows, making traditional defenses inadequate. The threat ecosystem has converged,...
Approaches to Rural Healthcare Need a Reality Check
Rural healthcare leaders often assume patients lack basic connectivity, but CNO Holly Davis argues that smartphones, telemedicine platforms, and emerging satellite internet services have dramatically narrowed the digital divide. While these technologies enable virtual visits and remote monitoring, persistent funding...
Biotech IPO Market Strengthens in 2026, but Quality Bar Remains High
Cooley partners Charlie Kim and Div Gupta told BioXconomy that biotech IPO activity is picking up in 2026, with a noticeable rise in deal volume and higher median valuations. They highlighted that investors are still demanding rigorous data packages and...
Registry Maps ‘Fragmented’ Health AI Policy Landscape
Researchers at Icahn School of Medicine at Mount Sinai introduced the Health & AI Policy Index (HAPI), a comprehensive registry that aggregates U.S. state, federal, international and voluntary health‑AI policies. An analysis of 240 policies from 2016‑2025 shows the governance landscape is...
6 Newly Formed Health Systems
Six new health systems debuted across the U.S. after mergers, bankruptcy exits, and nonprofit turnarounds. The entities range from Memorial Health System of Southwest Oklahoma’s 464‑bed merger to Hudson Regional Health’s $120 million‑backed restructuring of four New Jersey hospitals. Centralus Health...
New York Health System to Shutter ASC Amid Declining Patient Volume
Catholic Health System announced it will close the Sterling Surgical Center in Orchard Park, New York, citing a sharp drop in patient volume over the past year. The outpatient facility, which once performed about 8,600 surgeries annually with a staff of 28,...
Northwell Built a Medical School without Grades or Class Rank. Here’s Where It Stands, 15 Years In
The Donald and Barbara Zucker School of Medicine, launched in 2011 by Hofstra University and Northwell Health, abandoned grades and class rank, replacing traditional exams with essays, oral assessments, and high‑fidelity simulations while immersing students in clinical work from day...
Cancer Is Now a Story of the Good, the Bad and the Ugly – but Also Hope | Devi Sridhar
At the American Society of Clinical Oncology meeting, a new oral drug, daraxonrasib, doubled five‑year survival for pancreatic cancer patients in a 500‑person trial, offering a rare breakthrough for a disease with historically poor outcomes. A concurrent head‑and‑neck cancer vaccine,...
Potential Big Impact If Firms That Own Pharmacy Benefit Managers Must Break Up
A bipartisan "Patients Before Monopolies Act" would bar health insurers that own pharmacy benefit managers (PBMs) from also owning retail pharmacies, giving firms like Cigna, CVS Health and UnitedHealth a year to divest. The proposal targets specialty pharmacies, which now...
HCA Hospital in Tennessee Names COO
HCA Healthcare announced that Sam Younger, PhD, MSN, will become chief operating officer of TriStar Summit Medical Center in Hermitage, Tennessee, effective June 1. Younger previously served as COO of TriStar Greenview Regional Hospital in Bowling Green, Kentucky, also an HCA facility....
Smart Drug that Strips Cancer Cells of ‘Invisibility Cloak’ Can Shrink Tumours by 30%, Trial Shows
Researchers at Oxford’s Greywolf Therapeutics reported that the oral drug GRWD5769, when paired with cemiplimab immunotherapy, caused tumor shrinkage in 26 of 83 heavily pre‑treated patients across six common cancer types. Fifteen of those patients saw reductions of at least...
The Link Between HIV and Chronic Pain
Over half of people living with HIV suffer chronic pain, a condition that remains hard to treat. A new study in the Journal of Neuroscience shows that the HIV envelope protein gp120, when injected into the mouse spinal cord, boosts...
Prescription Drug Prior Authorization: Costs to Pharmacies and Physicians
A systematic review of 14 U.S. studies quantifies the labor costs of prescription‑drug prior authorizations (PAs) in outpatient settings. Health‑system pharmacies spend 15‑24 minutes per PA, costing $15‑$63, while physician practices require 25‑64 minutes, costing $16‑$49. The analysis highlights substantial...
Epic Integrates Firearm Injury Risk Screening Tool From Northwell Health
Northwell Health’s NIH‑funded "We Ask Everyone" firearm injury risk screening tool has been embedded in Epic’s electronic health record platform. The digital module identifies patients at risk, provides free gun locks, and connects them to hospital‑based violence‑intervention services while capturing...
Vandalia Health CFO Begins New Role as CEO
Jeff Sandene, previously executive vice president and CFO of Vandalia Health, assumed the role of president and chief executive on June 1. The promotion, originally slated for July after Dave Ramsey’s retirement, was accelerated when Pat Keel was appointed as the...
Arkansas Children’s Taps Chief Research Officer, Institute President
Arkansas Children’s announced that Dr. Tamara Perry will assume the role of senior vice president and chief research officer, effective July 1, while also becoming president of the Arkansas Children’s Research Institute. Perry, a longtime employee with nearly two decades at...
Ahead of Becker’s ASC: Kathy Saunders on Denials, Underpayments and Scaling RCM in Orthopedics
Kathy Saunders, SVP of revenue cycle management at Redefine Healthcare, explained how denials, underpayments and staffing pressures are reshaping revenue cycle management for orthopedics groups using athenahealth. She highlighted that the Adonis analytics platform enables proactive, batch‑level denial detection and...